Nasal CPAP 300
Neonatal
A full 60% of the infants born after 28 weeks of pregnancy or less are prone to respiratory distress syndrome (RDS). The lungs of these infants are underdeveloped, and the required gas exchange cannot take place. Hence their breathing needs external support.
NCPAP 300 is a simple continuous positive airway pressure (CPAP) system designed to provide support to fragile infants suffering from RDS. NCPAP 300 prevents airway closure and maintains the functional residual capacity. It has been ergonomically designed and is remarkably easy to operate.
- Flow and bubble: Versatile—can be configured for both flow and bubble operation according to your preference.
- Display unit: Values of respiratory parameters displayed in large, bright characters for easy reading.
- Compact electronic blender: Accurate delivery of gases with precise control of the proportion of air and oxygen.
- Lightweight patient interface: Designed to eliminate damage to the nasal septum and delicate nostrils of the infant.
- Universal circuit interface: Compatible with different circuits available in the market.
- “Shut Down” alarm: Continuous monitoring of pressure , FiO2 and apnea with an alert system.
